Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-02

Clinical Trial Update: Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population

View source ↗

Summary

This completed clinical trial examined the pharmacokinetics of four antiretroviral drugs—tenofovir disoproxil fumarate, emtricitabine, efavirenz, and atazanavir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtriva (emtricitabine)
  • REYATAZ (atazanavir)
  • Sustiva (efavirenz)
  • Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Human Immunodeficiency Virus | Status: COMPLETED